Literature DB >> 9505143

M-CSF: haematopoietic growth factor or inflammatory cytokine?

P Fixe1, V Praloran.   

Abstract

Macrophage colony-stimulating factor (M-CSF), initially described as a growth factor of the mononuclear phagocytic lineage, also participates in immunological and inflammatory reactions, bone metabolism and pregnancy. All its biological activities are mediated by a tyrosine kinase receptor (M-CSF-R) that is encoded by the c-fms protooncogene. After a brief overview on the synthesis, structure, metabolism and signalling of M-CSF and its receptor, we present with more details the major in vitro and/or in vivo biological activities of this cytokine. A particular attention has been devoted to the results suggesting that the various M-CSF isoforms (i.e. soluble, cell-associated and matrix anchored forms) play different specific roles on target cells bearing M-CSF-R at their surface. Infectious, inflammatory and neoplastic diseases in which M-CSF is involved and could participate to their physiopathology are mentioned. Finally, the role that the various isoforms of M-CSF could play in the regulation of "physiological and pathological cytokine networks" during inflammatory and immune responses is discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9505143     DOI: 10.1006/cyto.1997.0249

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  21 in total

Review 1.  Cellular cofactors for amyloid beta-peptide-induced cell stress. Moving from cell culture to in vivo.

Authors:  S D Yan; A Roher; A M Schmidt; D M Stern
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

Review 2.  LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies.

Authors:  Anna P Lillis; Lauren B Van Duyn; Joanne E Murphy-Ullrich; Dudley K Strickland
Journal:  Physiol Rev       Date:  2008-07       Impact factor: 37.312

3.  Development of disseminated histiocytic sarcoma in a patient with autoimmune lymphoproliferative syndrome and associated Rosai-Dorfman disease.

Authors:  Girish Venkataraman; Kenneth L McClain; Stefania Pittaluga; V Koneti Rao; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2010-04       Impact factor: 6.394

4.  Airway Epithelial Cell-Derived Colony Stimulating Factor-1 Promotes Allergen Sensitization.

Authors:  Hyung-Geun Moon; Seung-Jae Kim; Jong Jin Jeong; Seon-Sook Han; Nizar N Jarjour; Hyun Lee; Sherry L Abboud-Werner; Sangwoon Chung; Hak Soo Choi; Viswanathan Natarajan; Steven J Ackerman; John W Christman; Gye Young Park
Journal:  Immunity       Date:  2018-07-24       Impact factor: 31.745

5.  Exploring the relationship of macrophage colony-stimulating factor levels on neuroaxonal metabolism and cognition during chronic human immunodeficiency virus infection.

Authors:  Margaret R Lentz; Mahaveer Degaonkar; Mona A Mohamed; Hyun Kim; Katherine Conant; Elkan F Halpern; Ned Sacktor; Peter B Barker; Martin G Pomper
Journal:  J Neurovirol       Date:  2010-10       Impact factor: 2.643

Review 6.  Functional alterations of proinflammatory monocytes by T regulatory cells: implications for the prevention and reversal of type 1 diabetes.

Authors:  Charles Sia; Arno Hänninen
Journal:  Rev Diabet Stud       Date:  2010-05-10

7.  Effects of ethanol on NF-kappaB activation, production of myeloid growth factors, and adhesive events in human endothelial cells.

Authors:  A S Jonsson; J E Palmblad
Journal:  J Infect Dis       Date:  2001-08-13       Impact factor: 5.226

8.  Targeting extracellular signal-regulated kinase (ERK) signaling has therapeutic implications for inflammatory osteolysis.

Authors:  Sung Wook Seo; Daniel Lee; Hiroshi Minematsu; Abraham D Kim; Mike Shin; Samuel K Cho; Dae Won Kim; Jay Yang; Francis Y Lee
Journal:  Bone       Date:  2009-11-04       Impact factor: 4.398

Review 9.  Macrophage colony-stimulating factor in the pathogenesis of HIV infection: potential target for therapeutic intervention.

Authors:  Valerie Haine; Tracy Fischer-Smith; Jay Rappaport
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 4.147

10.  Increased macrophage colony-stimulating factor levels in patients with Graves' disease.

Authors:  Eriko Morishita; Akiko Sekiya; Tomoe Hayashi; Yasuko Kadohira; Mio Maekawa; Masahide Yamazaki; Hidesaku Asakura; Shinji Nakao; Shigeki Ohtake
Journal:  Int J Hematol       Date:  2008-08-27       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.